In vitro evaluation on the effects of combined lamivudine (3TC) and Ara-AMP against hepatitis B virus.
- Author:
Haibin SU
1
;
Huifen WANG
;
Wei JI
;
Yanling ZHAO
;
Guangming CAI
Author Information
- Publication Type:Journal Article
- MeSH: Antiviral Agents; pharmacology; DNA, Viral; drug effects; metabolism; Dose-Response Relationship, Drug; Drug Synergism; Hepatitis B virus; drug effects; Humans; In Vitro Techniques; Lamivudine; pharmacology; Vidarabine Phosphate; pharmacology
- From: Chinese Journal of Experimental and Clinical Virology 2002;16(1):16-19
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUNDTo evaluate the inhibitive effect of combination of 3TC with Ara-AMP against HBV in vitro.
METHODSUsed 2.2.15 cell as target cell. With radioimmunological technique and blot slot, the inhibitive effect of 3TC, Ara-AMP and the combination of both against the HBsAg, HBeAg and intracellular HBV DNA were investigated.
RESULTSThe inhibitive ratio of Ara-AMP against HBsAg, HBeAg was 45.48% and 41.46% respectively when its concentration was 400.0 microgram/ml. Although 3TC also has inhibitive effect in its experimental concentration, its effect is weaker. When Ara-AMP 50.0 microgram/ml was combined with 3TC 1.25 and 5.00 microgram/ml respectively, the inhibitive ratio against HBsAg were 19.92% and 17.32% respectively. Compared with using same concentration 3TC alone, the difference of results was significant (P<0.05). But when compared with using the same concentration Ara-AMP alone, the difference of results had no statistical significance (P <0.05). Remarkable inhibitive effects of combination of 3TC with Ara-AMP against HBeAg were n ot found. When 3TC 5.00 microgram/ml was combined with Ara-AMP 12.5 and 50.0 microgram/ml respectively, the inhibitive ratio against HBV DNA was 45.90% and 50.36% respectively. Comparing the content of HBV DNA in these groups with that of control group and the groups using the same concentration 3TC and Ara-AMP alone, the differences were significant (P <0.05).
CONCLUSIONSCombination of 3TC with Ara-AMP could enhance the inhibitive effects against HBV DNA.